These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16387130

  • 1. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
    Neff GW, Shire N, Ruiz P, O'Brien C, Garcia M, Dela Garza J, Rudich SR, Reddy KR.
    Transplant Proc; 2005 Dec; 37(10):4397-402. PubMed ID: 16387130
    [Abstract] [Full Text] [Related]

  • 2. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 3. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M, Seaberg E.
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [Abstract] [Full Text] [Related]

  • 4. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F.
    Transplantation; 2008 Dec 27; 86(12):1666-71. PubMed ID: 19104402
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.
    Liver Transpl; 2004 Aug 27; 10(8):975-85. PubMed ID: 15390322
    [Abstract] [Full Text] [Related]

  • 6. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD, Lyden ER, Gulizia JM, McCashland TM.
    Liver Transpl; 2006 Jan 27; 12(1):134-9. PubMed ID: 16382465
    [Abstract] [Full Text] [Related]

  • 7. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW, O'Brien CB, Nery J, Shire NJ, Nishida S, delaGarza J, Montalbano M, Safdar K, Ruiz P, Rideman E, Gascon JA, Tzakis AG, Madariaga J, Rudich SM.
    Liver Transpl; 2004 Dec 27; 10(12):1497-503. PubMed ID: 15558835
    [Abstract] [Full Text] [Related]

  • 8. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 27; 37(4):1700-2. PubMed ID: 15919436
    [Abstract] [Full Text] [Related]

  • 9. Early histologic changes in fibrosing cholestatic hepatitis C.
    Dixon LR, Crawford JM.
    Liver Transpl; 2007 Feb 27; 13(2):219-26. PubMed ID: 17205558
    [Abstract] [Full Text] [Related]

  • 10. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, Edwards E, Taranto S, Johnson LB.
    Liver Transpl; 2001 Sep 27; 7(9):762-8. PubMed ID: 11552208
    [Abstract] [Full Text] [Related]

  • 11. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K, Davidson BR, Patch DW, Burroughs AK.
    Transpl Infect Dis; 2006 Mar 27; 8(1):3-12. PubMed ID: 16623815
    [Abstract] [Full Text] [Related]

  • 12. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
    Smallwood GA, Devine R, Fasola C, Stieber AC, Heffron TG.
    Transplantation; 2008 Dec 27; 86(12):1795-8. PubMed ID: 19104424
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May 27; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of acute rejection after interferon therapy in liver transplant recipients.
    Saab S, Kalmaz D, Gajjar NA, Hiatt J, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Goldstein LI, Lassman CR, Busuttil RW.
    Liver Transpl; 2004 Jul 27; 10(7):859-67. PubMed ID: 15237369
    [Abstract] [Full Text] [Related]

  • 15. Retransplantation for late liver graft failure: predictors of mortality.
    Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA.
    Liver Transpl; 2000 Mar 27; 6(2):174-9. PubMed ID: 10719016
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb 27; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 17. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR.
    Liver Transpl; 2002 Sep 27; 8(9):814-21. PubMed ID: 12200784
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, McCaughan GW.
    Liver Transpl; 2002 Mar 27; 8(3):292-301. PubMed ID: 11910576
    [Abstract] [Full Text] [Related]

  • 19. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
    Barcena R, Oton E, Barreales M, Castillo M, Blesa C.
    Transplant Proc; 2006 Oct 27; 38(8):2502-4. PubMed ID: 17097981
    [Abstract] [Full Text] [Related]

  • 20. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK.
    Liver Transpl; 2001 May 27; 7(5):436-41. PubMed ID: 11349265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.